· Published by Health Canada · Official notice
| Product Name | Dosage Form | Brand | Lot | Market Authorization | Strength |
|---|---|---|---|---|---|
| Dotarem Injection | Solution | Dotarem | 20GD087B02 | DIN 02459329 | Gadoterate Meglumine 376.9 mg/ml, equivalent to 0.5 mmol/ml |
Product sterility may be compromised in the affected lot due to the possibility of defects in the vial.